Paying users zone. Data is covered by hidden.

  • Get to Allergan PLC for $15.99, or

  • get to whole website for at least 3 months from $49.99.

Microsoft Excel LibreOffice Calc

Allergan PLC (AGN)

Profitability Analysis

Difficulty: Beginner

  • Annual Data
  • Quarterly Data

    • Profitability ratios measure the company's ability to generate profitable sales from its resources (assets).

    Ratios (Summary)

    Allergan PLC, profitability ratios

    Microsoft Excel LibreOffice Calc
    Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
    Return on Sales
    Gross profit margin hidden% hidden% hidden% hidden% hidden%
    Operating profit margin hidden% hidden% hidden% hidden% hidden%
    Net profit margin hidden% hidden% hidden% hidden% hidden%
    Return on Investment
    Return on equity (ROE) hidden% hidden% hidden% hidden% hidden%
    Return on assets (ROA) hidden% hidden% hidden% hidden% hidden%

    Source: Based on data from Allergan PLC Annual Reports

    Ratio Description The company
    Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. Allergan PLC's gross profit margin improved from 2015 to 2016 but then slightly deteriorated from 2016 to 2017.
    Operating profit margin A profitability ratio calculated as operating income divided by revenue. Allergan PLC's operating profit margin improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.
    Net profit margin An indicator of profitability, calculated as net income divided by revenue. Allergan PLC's net profit margin improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.
    ROE A profitability ratio calculated as net income divided by shareholders' equity. Allergan PLC's ROE improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.
    ROA A profitability ratio calculated as net income divided by total assets. Allergan PLC's ROA improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.

    Gross Profit Margin

    Allergan PLC, gross profit margin calculation

    Microsoft Excel LibreOffice Calc
    Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
    Selected Financial Data (USD $ in thousands)
    Gross profit hidden hidden hidden hidden hidden
    Net revenues hidden hidden hidden hidden hidden
    Ratio
    Gross profit margin1 hidden% hidden% hidden% hidden% hidden%
    Benchmarks
    Gross Profit Margin, Competitors
    Abbott Laboratories hidden% hidden% hidden% hidden% hidden%
    AbbVie Inc. hidden% hidden% hidden% hidden% hidden%
    Amgen Inc. hidden% hidden% hidden% hidden% hidden%
    Biogen Inc. hidden% hidden% hidden% hidden% hidden%
    Bristol-Myers Squibb Co. hidden% hidden% hidden% hidden% hidden%
    Celgene Corp. hidden% hidden% hidden% hidden% hidden%
    Eli Lilly & Co. hidden% hidden% hidden% hidden% hidden%
    Gilead Sciences Inc. hidden% hidden% hidden% hidden% hidden%
    Johnson & Johnson hidden% hidden% hidden% hidden% hidden%
    Merck & Co. Inc. hidden% hidden% hidden% hidden% hidden%
    Pfizer Inc. hidden% hidden% hidden% hidden% hidden%
    Regeneron Pharmaceuticals Inc. hidden% hidden% hidden% hidden% hidden%

    Source: Based on data from Allergan PLC Annual Reports

    2017 Calculations

    1 Gross profit margin = 100 × Gross profit ÷ Net revenues
    = 100 × hidden ÷ hidden = hidden%

    Ratio Description The company
    Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. Allergan PLC's gross profit margin improved from 2015 to 2016 but then slightly deteriorated from 2016 to 2017.

    Operating Profit Margin

    Allergan PLC, operating profit margin calculation, comparison to benchmarks

    Microsoft Excel LibreOffice Calc
    Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
    Selected Financial Data (USD $ in thousands)
    Operating loss hidden hidden hidden hidden hidden
    Net revenues hidden hidden hidden hidden hidden
    Ratio
    Operating profit margin1 hidden% hidden% hidden% hidden% hidden%
    Benchmarks
    Operating Profit Margin, Competitors
    Abbott Laboratories hidden% hidden% hidden% hidden% hidden%
    AbbVie Inc. hidden% hidden% hidden% hidden% hidden%
    Amgen Inc. hidden% hidden% hidden% hidden% hidden%
    Biogen Inc. hidden% hidden% hidden% hidden% hidden%
    Bristol-Myers Squibb Co. hidden% hidden% hidden% hidden% hidden%
    Celgene Corp. hidden% hidden% hidden% hidden% hidden%
    Eli Lilly & Co. hidden% hidden% hidden% hidden% hidden%
    Gilead Sciences Inc. hidden% hidden% hidden% hidden% hidden%
    Johnson & Johnson hidden% hidden% hidden% hidden% hidden%
    Merck & Co. Inc. hidden% hidden% hidden% hidden% hidden%
    Pfizer Inc. hidden% hidden% hidden% hidden% hidden%
    Regeneron Pharmaceuticals Inc. hidden% hidden% hidden% hidden% hidden%
    Operating Profit Margin, Sector
    Pharmaceuticals & Biotechnology hidden% hidden% hidden% hidden% hidden%
    Operating Profit Margin, Industry
    Health Care hidden% hidden% hidden% hidden% hidden%

    Source: Based on data from Allergan PLC Annual Reports

    2017 Calculations

    1 Operating profit margin = 100 × Operating loss ÷ Net revenues
    = 100 × hidden ÷ hidden = hidden%

    Ratio Description The company
    Operating profit margin A profitability ratio calculated as operating income divided by revenue. Allergan PLC's operating profit margin improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.

    Net Profit Margin

    Allergan PLC, net profit margin calculation, comparison to benchmarks

    Microsoft Excel LibreOffice Calc
    Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
    Selected Financial Data (USD $ in thousands)
    Net income (loss) attributable to shareholders hidden hidden hidden hidden hidden
    Net revenues hidden hidden hidden hidden hidden
    Ratio
    Net profit margin1 hidden% hidden% hidden% hidden% hidden%
    Benchmarks
    Net Profit Margin, Competitors
    Abbott Laboratories hidden% hidden% hidden% hidden% hidden%
    AbbVie Inc. hidden% hidden% hidden% hidden% hidden%
    Amgen Inc. hidden% hidden% hidden% hidden% hidden%
    Biogen Inc. hidden% hidden% hidden% hidden% hidden%
    Bristol-Myers Squibb Co. hidden% hidden% hidden% hidden% hidden%
    Celgene Corp. hidden% hidden% hidden% hidden% hidden%
    Eli Lilly & Co. hidden% hidden% hidden% hidden% hidden%
    Gilead Sciences Inc. hidden% hidden% hidden% hidden% hidden%
    Johnson & Johnson hidden% hidden% hidden% hidden% hidden%
    Merck & Co. Inc. hidden% hidden% hidden% hidden% hidden%
    Pfizer Inc. hidden% hidden% hidden% hidden% hidden%
    Regeneron Pharmaceuticals Inc. hidden% hidden% hidden% hidden% hidden%
    Net Profit Margin, Sector
    Pharmaceuticals & Biotechnology hidden% hidden% hidden% hidden% hidden%
    Net Profit Margin, Industry
    Health Care hidden% hidden% hidden% hidden% hidden%

    Source: Based on data from Allergan PLC Annual Reports

    2017 Calculations

    1 Net profit margin = 100 × Net income (loss) attributable to shareholders ÷ Net revenues
    = 100 × hidden ÷ hidden = hidden%

    Ratio Description The company
    Net profit margin An indicator of profitability, calculated as net income divided by revenue. Allergan PLC's net profit margin improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.

    Return on Equity (ROE)

    Allergan PLC, ROE calculation, comparison to benchmarks

    Microsoft Excel LibreOffice Calc
    Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
    Selected Financial Data (USD $ in thousands)
    Net income (loss) attributable to shareholders hidden hidden hidden hidden hidden
    Shareholders' equity hidden hidden hidden hidden hidden
    Ratio
    ROE1 hidden% hidden% hidden% hidden% hidden%
    Benchmarks
    ROE, Competitors
    Abbott Laboratories hidden% hidden% hidden% hidden% hidden%
    AbbVie Inc. hidden% hidden% hidden% hidden% hidden%
    Amgen Inc. hidden% hidden% hidden% hidden% hidden%
    Biogen Inc. hidden% hidden% hidden% hidden% hidden%
    Bristol-Myers Squibb Co. hidden% hidden% hidden% hidden% hidden%
    Celgene Corp. hidden% hidden% hidden% hidden% hidden%
    Eli Lilly & Co. hidden% hidden% hidden% hidden% hidden%
    Gilead Sciences Inc. hidden% hidden% hidden% hidden% hidden%
    Johnson & Johnson hidden% hidden% hidden% hidden% hidden%
    Merck & Co. Inc. hidden% hidden% hidden% hidden% hidden%
    Pfizer Inc. hidden% hidden% hidden% hidden% hidden%
    Regeneron Pharmaceuticals Inc. hidden% hidden% hidden% hidden% hidden%
    ROE, Sector
    Pharmaceuticals & Biotechnology hidden% hidden% hidden% hidden% hidden%
    ROE, Industry
    Health Care hidden% hidden% hidden% hidden% hidden%

    Source: Based on data from Allergan PLC Annual Reports

    2017 Calculations

    1 ROE = 100 × Net income (loss) attributable to shareholders ÷ Shareholders' equity
    = 100 × hidden ÷ hidden = hidden%

    Ratio Description The company
    ROE A profitability ratio calculated as net income divided by shareholders' equity. Allergan PLC's ROE improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.

    Return on Assets (ROA)

    Allergan PLC, ROA calculation, comparison to benchmarks

    Microsoft Excel LibreOffice Calc
    Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
    Selected Financial Data (USD $ in thousands)
    Net income (loss) attributable to shareholders hidden hidden hidden hidden hidden
    Total assets hidden hidden hidden hidden hidden
    Ratio
    ROA1 hidden% hidden% hidden% hidden% hidden%
    Benchmarks
    ROA, Competitors
    Abbott Laboratories hidden% hidden% hidden% hidden% hidden%
    AbbVie Inc. hidden% hidden% hidden% hidden% hidden%
    Amgen Inc. hidden% hidden% hidden% hidden% hidden%
    Biogen Inc. hidden% hidden% hidden% hidden% hidden%
    Bristol-Myers Squibb Co. hidden% hidden% hidden% hidden% hidden%
    Celgene Corp. hidden% hidden% hidden% hidden% hidden%
    Eli Lilly & Co. hidden% hidden% hidden% hidden% hidden%
    Gilead Sciences Inc. hidden% hidden% hidden% hidden% hidden%
    Johnson & Johnson hidden% hidden% hidden% hidden% hidden%
    Merck & Co. Inc. hidden% hidden% hidden% hidden% hidden%
    Pfizer Inc. hidden% hidden% hidden% hidden% hidden%
    Regeneron Pharmaceuticals Inc. hidden% hidden% hidden% hidden% hidden%
    ROA, Sector
    Pharmaceuticals & Biotechnology hidden% hidden% hidden% hidden% hidden%
    ROA, Industry
    Health Care hidden% hidden% hidden% hidden% hidden%

    Source: Based on data from Allergan PLC Annual Reports

    2017 Calculations

    1 ROA = 100 × Net income (loss) attributable to shareholders ÷ Total assets
    = 100 × hidden ÷ hidden = hidden%

    Ratio Description The company
    ROA A profitability ratio calculated as net income divided by total assets. Allergan PLC's ROA improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.